Carl Goldfischer, Director at CymaBay Therapeutics, Inc. (CBAY), sold 18,000 shares at $8.66 ($156K) on 2017-11-02, disclosed to the SEC on 2017-11-06.
Open-market sale of $156k CBAY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CBAY | SELL | 2018-03-23 | $195K | — | Filing → |
| ETRM | SELL | 2017-05-31 | $23K | — | Filing → |
| EPZM | BUY | 2016-01-12 | $5.0M | — | Filing → |